InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: Steve43 post# 28886

Saturday, 03/23/2013 1:06:36 PM

Saturday, March 23, 2013 1:06:36 PM

Post# of 330578
Oooops, almost forgot these two facts!
Alex Gorsky was recently appointed, let's see, Chairman BOD, CEO, Chairman of the Executive Committee of J&J. His previous assignment was Director of the J&J devices division. I just looked at the list and mini-bios of J&J's 13 directors - do you think just one of those tremendously accomplished people might just ask the question, "should we increase our presence in the pain treatment device space?"

Then the other fact is that Gregor Forbes, heading up Gro-International, while he doesn't have the guns of Alex Gorsky, does have 28 years in the OTC pharma space, 25 of them with P&G.

None of this is to say anything is in the wind or I'm pumping anything, I just find it interesting and nothing would suprise me given that BIEL products are drug free, treat pain and promote healing of compromised tissue. The FDA has already approved that RecoveryRX is safe when prescribed to post-op patients having opthalmic surgery. That would be the eye area, close to the brain!

And if I'm Whelan at BIEL, I'm talking to both J&J and P&G to at least keep the lines of communication open. I see Whelan as a stubborn, somewhat aging ex-US Marine, who for a time probably wanted to go it alone, Founder's Syndrome, but even those types have to eat and Whelan could eat very, very well, as I see it.